Associate Chief, Nephrology Medical Director Kidney Transplantation
Nephrology
Dr. Ronald D. Perrone, MD
|
|
Give Review
Ronald Perrone works in the field of Nephrology. He went to medical school at Drexel University College of Medicine. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Boston Magazine", "Boston Herald", "Fellow (ASNF)", "Super Doctor" and "Top MD". Ronald D. Perrone is also published. He has 56 publications published. The lastest publication: "Post-therapy iodine-131 localization in unsuspected large renal cyst: possible mechanisms.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
- Vascular complications in autosomal dominant polycystic Kidney disease.
- Liver involvement in early autosomal-dominant polycystic Kidney disease.
- Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease.
- Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease.
- Filling the Holes in Cystic Kidney Disease Research.
- Health-Related Quality of Life in Patients With Autosomal Dominant Polycystic Kidney Disease and CKD Stages 1-4: A Cross-sectional Study.
- Economic burden and resource use associated with autosomal dominant polycystic Kidney disease among a medicare population.
- The regulation of cystogenesis in a tissue engineered Kidney disease system by abnormal matrix interactions.
- Analysis of baseline parameters in the HALT polycystic Kidney disease trials.
- Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study.
- Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic Kidney disease.
- mTOR inhibitors and autosomal dominant polycystic Kidney disease.
- Management of ESRD in patients with autosomal dominant polycystic Kidney disease.
- The HALT polycystic Kidney disease trials: design and implementation.
- Managing cyst infections in ADPKD: an old problem looking for new answers.
- Hypertension in individuals at risk for autosomal dominant polycystic Kidney disease: to screen or not to screen?
- Medical resource utilization and costs associated with autosomal dominant polycystic Kidney disease in the USA: a retrospective matched cohort analysis of private insu...
- Making an earlier diagnosis of ADPKD: implications for the treatment of Hypertension.
- National Kidney Foundation practice guidelines for chronic Kidney disease: evaluation, classification, and stratification.
- Effects of fish oil supplementation on Kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials.
- The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic Kidney disease.
- Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic Kidney disease.
- Inflammation, oxidative stress, and insulin resistance in polycystic Kidney disease.
- Reproductive issues for adults with autosomal dominant polycystic Kidney disease.
- Survival after end-stage renal disease in autosomal dominant polycystic Kidney disease: contribution of extrarenal complications to mortality.
- Imaging progression in polycystic Kidney disease.
- Experimental renal Failure in the rat modulates cardiac Na,K-ATPase alpha 2 mRNA but not protein.
- Serum creatinine as an index of Renal function: new insights into old concepts.
- Serum creatinine and Renal function.
- Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium.
- Utility of radioisotopic filtration markers in Chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modifi...
- Autosomal dominant polycystic Kidney disease decreases anion exchanger activity.
- Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic Kidney disease.
- ExtraRenal manifestations of ADPKD.
- Cyst function in polycystic Kidney disease: nongradient cysts.
- Tissue-engineered three-dimensional in vitro models for normal and diseased Kidney.
- Post-therapy iodine-131 localization in unsuspected large Renal cyst: possible mechanisms.
- Effects of omega-3 fatty acids on organ transplantation.
- Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart Failure.
- Eating disorder in a hemodialysis patient: case report.
- Means of clinical evaluation of renal Disease progression.
- Maintenance Immunosuppression with Intermittent Intravenous IL-2 Receptor Antibody Therapy in Renal Transplant Recipients (September).
- Aldosterone and PCO2 enhance rubidium absorption in rat distal colon.
- Aldosterone and PCO2 enhance K-dependent chloride absorption in rat distal colon.
- Secondary hyperaldosteronism stimulates acidification in rat distal colon.
- Correction of the Cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines.
- Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines.
- Aldosterone induces apical vesicles in rat distal colon.
- Purinoceptor P2U identification and function in human intrahepatic biliary epithelial cell lines.
- Immortalized human bladder cell line exhibits amiloride-sensitive sodium absorption.
- Rat kidney band 3 mRNA modulation in chronic respiratory Acidosis.
- Vascular access for hemodialysis.
- Water channel expression in human ADPKD Kidneys.
- Diet, indicators of Kidney disease, and later mortality among older persons in the NHANES I Epidemiologic Follow-Up Study.
Schools
Hahnemann University
Grady Memorial Hospital
Boston Med Center
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Boston Magazine
- Boston Herald
- Fellow (ASNF)
- Super Doctor
- Top MD
Education
-
Boston University Medical Center -
Drexel University College of Medicine
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1265541155 | |
| NPPES Provider LastName | PERRONE | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 112.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265541155 |
| Last Name Of The Provider | PERRONE |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Patricia A. Suzman, MD |
|
|
Dr. Chunmei Huang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ishir Bhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julian L. Seifter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Opeyemi A. Olabisi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Conall M. O Seaghdha, MD |
|
|
Dr. Eliyahu Khankin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose C. Da Silva, MD |
|
|
Dr. Julie Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radhika Venugopal, MD
This Doctor is OpenDoctor Recommended.
|